Lexeo Therapeutics, Inc.(LXEO)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
LXEO is scheduled to report on Nov 9, 2026, usually before the market opens. Analysts expect EPS of -$0.34.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 11 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.3%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 3 misses.
In plain words: it beat expectations 6 times, but the stock still fell 2 of those 6 times.
- Aug '26Missed▲ +1.9%
- May '26Beat▲ +5.0%
- Mar '26Beat▲ +8.9%
- Nov '25Beat▼ -1.8%
- Aug '25Missed▲ +1.5%
- Nov '24Missed▼ -0.7%
- Aug '24Beat▲ +4.2%
- May '24Beat▲ +5.7%
- Dec '23Beat▼ -12.9%
Clear beats and misses with a known reaction only. What counts as a beat
Why did LXEO fall after beating earnings?
4 of LXEO's last 9 reactions went against the EPS result. What stands out in each:
LXEO beat EPS estimates in 6 quarters, and the stock still closed lower the next day 2 times.
- Nov 5, 2025EPS beat +28.3%stock -1.8% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Dec 11, 2023EPS beat +60.3%stock -12.9% next day
- It had risen 6.8% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 5.1% lower as soon as trading resumed.
Rose despite an EPS miss (2 of 3)
- Aug 12, 2026EPS missed -7.1%stock +1.9% next day
- It opened 1.3% higher as soon as trading resumed.
- Aug 14, 2025EPS missed -3.0%stock +1.5% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was LXEO's earnings move already priced in?
LXEO's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does LXEO hold its opening gap after earnings?
LXEO's opening move after each report and where it closed that day.
In 7 reports LXEO opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. Gaps up faded 1 of 5; gaps down recovered 1 of 2.
- Aug 12, 2026HeldOpened +1.3%, closed +1.9%
- May 11, 2026HeldOpened +2.9%, closed +5.0%
- Mar 30, 2026HeldOpened +11.2%, closed +8.9%
- Mar 24, 2025HeldOpened +10.3%, closed +50.9%
- Nov 13, 2024ReversedOpened +12.5%, closed -0.7%
- May 9, 2024ReversedOpened -2.0%, closed +5.7%
- Dec 11, 2023HeldOpened -5.1%, closed -12.9%
LXEO earnings history
Last 11 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Before open | -$0.28 | -$0.30 | -7.1% | +1.88% | +1.26% |
| May 11, 2026 | Before open | -$0.30 | -$0.25 | +16.7% | +4.97% | -1.20% |
| Mar 30, 2026 | After close | -$0.30 | -$0.27 | +10.0% | +8.92% | +8.54% |
| Nov 5, 2025 | Before open | -$0.46 | -$0.33 | +28.3% | -1.80% | -1.92% |
| Aug 14, 2025 | Before open | -$0.66 | -$0.68 | -3.0% | +1.48% | +4.24% |
| May 12, 2025 | Before open | -$0.77 | -$0.99 | -28.6% | — | — |
| Mar 24, 2025 | Before open | -$0.78 | -$0.78 | 0.0% | +50.92% | +47.23% |
| Nov 13, 2024 | Before open | -$0.67 | -$0.89 | -32.8% | -0.65% | -13.52% |
| Aug 12, 2024 | Before open | -$0.69 | -$0.64 | +7.2% | +4.17% | +1.65% |
| May 9, 2024 | Before open | -$0.79 | -$0.77 | +2.5% | +5.69% | -1.17% |
| Dec 11, 2023 | Before open | -$3.02 | -$1.20 | +60.3% | -12.94% | +2.93% |
Consensus for the next report: EPS -$0.34, revenue $0.00.
LXEO Earnings FAQ
Answers computed from Lexeo Therapeutics, Inc.'s reported history
LXEO is scheduled to report on Nov 9, 2026, usually before the market opens. Analysts expect EPS of -$0.34.
Over the last 11 quarters with a usable EPS surprise, LXEO beat the consensus estimate 6 times (55%), missed 4 and landed in line 1.
Across its last 10 quarters with a measured reaction, LXEO moved an average of ±9.3% in the first session after reporting. It closed higher 70% of the time; the largest gain was 50.9% and the largest drop -12.9%.
LXEO fell in the first session after 2 of its last 6 EPS beats (33%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 10 quarters with price data, LXEO moved an average of -7.5% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (4 quarters), it fell the next day 25% of the time, averaging -1.0%. After a drop of 3% or more (4 quarters), it rose the next day 75% of the time, averaging +15.8%. This describes past reports; it is not a forecast.
In 7 reports LXEO opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 7 times (29%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · LXEO: 11 reported quarters, latest Aug 12, 2026. Information only, not investment advice.
Looking for more on LXEO?
Price charts, forecast, fundamentals and risk pages for LXEO are not on Tickzen yet. You can run a full stock analysis now.
Run the LXEO Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun